This presentation contains forward-looking statements that involve risks and
uncertainties, including but not limited to those related to the growth of the
home infusion market, our SG&A expenditures and the potential for Nasdaq
uplisting. Actual results and events may differ significantly from results and
events discussed in the forward-looking statements. Factors that might
cause or contribute to such differences include, but are not limited to,
economic and business conditions, trends and events around the world and
in the markets in which RMS operates, competitive pressure, customer
acceptance of new products, changes in medical reimbursement regulations,
regulatory approvals for new products, foreign regulations governing medical
devices, introduction of new technologies and those discussed in our
Transition Report on Form 10-K for the fiscal year ended December 31, 2017.
We undertake no obligation to update publicly this presentation or any
forward-looking statements to reflect new information, events, or
circumstances after the hereof.
Copy the link below into your browser for a replay of the webcast presentation: